Showing 41 - 60 results of 300 for search 'javaria~', query time: 4.52s Refine Results
  1. 41
  2. 42
  3. 43

    NIR “matchbox size” spectrometer can quantify and detect malaria infection in Plasmodium falciparum infected red blood cells by Adegoke, John A., Kochan, Kamila, Heraud, Philip, Wood, Bayden R.

    Published 2020
    “…New point-of-care diagnostic approaches for malaria that are highly sensitive, portable and affordable are urgently needed to meet the World Health Organization’s objective of reducing malaria cases and related life losses by at least 90% globally on or before 2030.1 In this study, an ultra-cheap matchbox size near-infrared (NIR) spectrophotometer was used for the first time to detect and quantify malaria infection in vitro from isolated dried red blood cells using a fingerpick volume (15 μl) of blood, down to 0.0001% parasitemia.…”
    Get full text
    Conference Paper
  4. 44

    Infections diagnosed in children and young people screened for malaria in UK emergency departments: a retrospective multi-centre study by Bird, C, Hayward, GN, Turner, PJ, Wasala, D, Merrick, V, Lyttle, MD, Mullen, N, Fanshawe, TR

    Published 2024
    “…</p> <br> <p><strong>Aims:</strong> To describe imported infections in CYP arriving from malaria-endemic areas and presenting to UK emergency departments (ED) who were screened for malaria.…”
    Journal article
  5. 45
  6. 46
  7. 47

    Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development by Mertens, JE, Rigby, CA, Bardelli, M, Quinkert, D, Hou, MM, Diouf, A, Silk, SE, Chitnis, CE, Minassian, AM, Moon, RW, Long, CA, Draper, SJ, Miura, K

    Published 2024
    “…Recent data indicate increasing disease burden and importance of Plasmodium vivax (Pv) malaria. A robust assay will be essential for blood-stage Pv vaccine development. …”
    Journal article
  8. 48
  9. 49

    Whole-cell phenotypic screening of Medicines for Malaria Venture Pathogen Box identifies specific inhibitors of Plasmodium falciparum late-stage development and egress by Patra, Alok Tanala, Hingamire, Tejashri, Belekar, Meenakshi A., Xiong, Aoli, Subramanian, Gowtham, Bozdech, Zbynek, Preiser, Peter, Shanmugam, Dhanasekaran, Chandramohanadas, Rajesh

    Published 2020
    “…We report a systematic, cellular phenotype-based antimalarial screening of the Medicines for Malaria Venture Pathogen Box collection, which facilitated the identification of specific blockers of late-stage intraerythrocytic development of Plasmodium falciparum First, from standard growth inhibition assays, we identified 173 molecules with antimalarial activity (50% effective concentration [EC50] ≤ 10 μM), which included 62 additional molecules over previously known antimalarial candidates from the Pathogen Box. …”
    Get full text
    Journal Article
  10. 50
  11. 51
  12. 52

    Cost of the national malaria control program and cost-effectiveness of indoor residual spraying and insecticide-treated bed net interventions in two districts of Madagascar by Andrianantoandro, VTA, Audibert, M, Kesteman, T, Ravolanjarasoa, L, Randrianarivelojosia, M, Rogier, C

    Published 2024
    “…Background: Madagascar has made significant progress in the fight against malaria. However, the number of malaria cases yearly increased since 2012. …”
    Journal article
  13. 53
  14. 54
  15. 55

    Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens by Barrett, JR, Silk, SE, Mkindi, CG, Kwiatkowska, KM, Hou, MM, Lias, AM, Kalinga, WF, Mtaka, IM, McHugh, K, Bardelli, M, Davies, H, King, LDW, Edwards, NJ, Chauhan, VS, Mukherjee, P, Rwezaula, S, Chitnis, CE, Olotu, AI, Minassian, AM, Draper, SJ, Nielsen, CM

    Published 2024
    “…We have previously reported primary endpoints of a clinical trial testing two vaccine platforms for the delivery of Plasmodium vivax malaria DBPRII: viral vectors (ChAd63, MVA), and protein/adjuvant (PvDBPII with 50µg Matrix-M™ adjuvant). …”
    Journal article
  16. 56

    A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border by Ansari, AT, Aung, KK, Win, HH, Beau, C, Nu, B, Soe, NL, Htoo, K, San, T, Wah, TG, Keereevijit, A, Phyo, AP, Chotivanich, K, White, NJ, Nosten, F, Hashmi, AH, Chu, CS

    Published 2025
    “…Background: The countries within the Greater Mekong Region of Southeast Asia have pledged to eliminate malaria by 2030. Elimination of Plasmodium vivax malaria is challenging as it requires radical cure to prevent relapse. …”
    Journal article
  17. 57
  18. 58
  19. 59
  20. 60